Skip to main content
. 2022 Feb 17;3(4):100298. doi: 10.1016/j.jtocrr.2022.100298

Table 3.

Known Groups Validity for NSCLC-SAQ Total Score at Baseline

Known Group Classification n LSmean (SE)a 95% CI p Value
PGIS-LC version 1.0 <0.0001
 Not severe 89 4.03 (0.36) 3.31–4.74
 Mildly severe 100 5.48 (0.34) 4.80–6.15
 Moderately severe 108 8.31 (0.33) 7.66–8.95
 Very severe/extremely severeb 46 10.70 (0.50) 9.70–11.69
PGIS-LC version 2.0
 No symptoms 38 4.43 (0.46) 3.52–5.35 <0.0001
 Mild 66 5.83 (0.35) 5.13–6.52
 Moderate 57 8.04 (0.38) 7.29–8.78
 Severe/very severeb 31 12.06 (0.51) 11.05–13.08
EORTC QLQ-C30 GHS/QoLc
 <58.8 209 9.39 (3.76) 8.88–9.90 <0.0001
 ≥58.8 326 5.25 (3.24) 4.90–5.61
ECOG performance statusd
 0 191 5.74 (3.87) 5.19–6.29 <0.0001
 1 345 7.50 (3.93) 7.09–7.92

CI, confidence interval; ECOG, Eastern Cooperative Oncology Group; EORTC QLQ-C30 GHS/QoL, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire core 30 Global Health Status/Quality of Life scale; LSmean, least square mean; NSCLC-SAQ, NSCLC Symptom Assessment Questionnaire; PGIS-LC, patient global impression of severity–lung cancer symptoms.

a

LS means were calculated using ANOVA Welch F-test, with α = 0.05 level.

b

Categories were combined owing to low cell counts.

c

Population reference value for NSCLC from EORTC QLQ-C30 reference values.16

d

ECOG performance status 0 means normal activity (fully active, able to carry on all predisease performance without restriction) whereas 1 means with symptoms but ambulatory (restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature [e.g., light housework, office work]).